Cargando…

The Broad Spectrum of LMNA Cardiac Diseases: From Molecular Mechanisms to Clinical Phenotype

Mutations of Lamin A/C gene (LMNA) cause laminopathies, a group of disorders associated with a wide spectrum of clinically distinct phenotypes, affecting different tissues and organs. Heart involvement is frequent and leads to cardiolaminopathy LMNA-dependent cardiomyopathy (LMNA-CMP), a form of dil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crasto, Silvia, My, Ilaria, Di Pasquale, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349320/ https://www.ncbi.nlm.nih.gov/pubmed/32719615 http://dx.doi.org/10.3389/fphys.2020.00761

Ejemplares similares

Phenotypic Variability in iPSC-Induced Cardiomyocytes and Cardiac Fibroblasts Carrying Diverse LMNA Mutations
por: Yang, Jiajia, et al.
Publicado: (2021)

Corrigendum: Phenotypic variability in iPSC-induced cardiomyocytes and cardiac fibroblasts carrying diverse LMNA mutations
por: Yang, Jiajia, et al.
Publicado: (2022)

The Emerging Role of Lamin C as an Important LMNA Isoform in Mechanophenotype
por: González-Cruz, Rafael D., et al.
Publicado: (2018)

Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics
por: Crasto, Silvia, et al.
Publicado: (2018)

Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases
por: Fermo, Elisa, et al.
Publicado: (2019)

Modeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic LMNA Mutations
por: Steele-Stallard, Heather B., et al.
Publicado: (2018)

Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations
por: Le Dour, Caroline, et al.
Publicado: (2022)

Unraveling LMNA Mutations in Metabolic Syndrome: Cellular Phenotype and Clinical Pitfalls
por: Desgrouas, Camille, et al.
Publicado: (2020)

Clinical Spectrum of LMNA-Associated Type 2 Familial Partial Lipodystrophy: A Systematic Review
por: Fernandez-Pombo, Antia, et al.
Publicado: (2023)

Novel mutations in LMNA A/C gene and associated phenotypes
por: Petillo, Roberta, et al.
Publicado: (2015)

Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells
por: Di Mauro, Vittoria, et al.
Publicado: (2019)

Diet-Induced Obesity Affects Muscle Regeneration After Murine Blunt Muscle Trauma—A Broad Spectrum Analysis
por: Xu, Pengfei, et al.
Publicado: (2018)

Characterization of cardiac involvement in children with LMNA-related muscular dystrophy
por: Cesar, Sergi, et al.
Publicado: (2023)

Cardiac glycosides are broad-spectrum senolytics
por: Guerrero, Ana, et al.
Publicado: (2019)

Clinical spectrum and genetic variations of LMNA-related muscular dystrophies in a large cohort of Chinese patients
por: Fan, Yanbin, et al.
Publicado: (2021)

Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of LMNA Mutation Carriers?
por: Chmielewski, Przemyslaw, et al.
Publicado: (2020)

Expression of mouse beta defensin 2 in escherichia coli and its broad-spectrum antimicrobial activity
por: Gong, Tianxiang, et al.
Publicado: (2011)

Clinical disease presentation and ECG characteristics of LMNA mutation carriers
por: Ollila, Laura, et al.
Publicado: (2017)

LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014)

Epigenetics in LMNA-Related Cardiomyopathy
por: Wang, Yinuo, et al.
Publicado: (2023)

Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy
por: Zhang, Xiaolin, et al.
Publicado: (2021)

Phenotypic Differences Among Familial Partial Lipodystrophy Due to LMNA or PPARG Variants
por: Vasandani, Chandna, et al.
Publicado: (2022)

Air pollution and adverse cardiac remodeling: clinical effects and basic mechanisms
por: Liu, Yonggang, et al.
Publicado: (2015)

A novel LMNA mutation identified in a Japanese patient with LMNA-associated congenital muscular dystrophy
por: Ishiyama, Akihiko, et al.
Publicado: (2018)

Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna (−/−) Mice
por: Frock, Richard L., et al.
Publicado: (2012)

Challenging the “chromatin hypothesis” of cardiac laminopathies with LMNA mutant iPS cells
por: Mozzetta, Chiara, et al.
Publicado: (2019)

Novel LMNA mutations in Greek and Myanmar Patients with Progeroid Features and Cardiac Manifestations
por: Kandhaya-Pillai, Renuka, et al.
Publicado: (2020)

LMNA Mutation in a Family with a Strong History of Sudden Cardiac Death
por: Keil, Laura, et al.
Publicado: (2022)

The Broad Clinical Spectrum of Epilepsies Associated With Protocadherin 19 Gene Mutation
por: Dell'Isola, Giovanni Battista, et al.
Publicado: (2022)

Looking at New Unexpected Disease Targets in LMNA-Linked Lipodystrophies in the Light of Complex Cardiovascular Phenotypes: Implications for Clinical Practice
por: Mosbah, Héléna, et al.
Publicado: (2020)

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study
por: Astrea, Guja, et al.
Publicado: (2018)

Phenotype–Genotype Analysis of Chinese Patients with Early-Onset LMNA-Related Muscular Dystrophy
por: Tan, Dandan, et al.
Publicado: (2015)

Mitochondria in Cardiac Postconditioning
por: Pagliaro, Pasquale, et al.
Publicado: (2018)

Metreleptin therapy in LMNA-linked lipodystrophies
por: Vatier, Camille, et al.
Publicado: (2015)

LMNA cardiomyopathy: cell biology and genetics meet clinical medicine
por: Lu, Jonathan T., et al.
Publicado: (2011)

Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum
por: Gallo, Giovanna, et al.
Publicado: (2021)

Editorial: Sport activity: From beneficial effects to cardiac disease
por: Romagnolo, Davide, et al.
Publicado: (2022)

The Processes and Mechanisms of Cardiac and Pulmonary Fibrosis
por: Murtha, Lucy A., et al.
Publicado: (2017)

Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype
por: Marques, Mayra de A., et al.
Publicado: (2016)

Correction: Cardiomyocyte-Specific Expression of Lamin A Improves Cardiac Function in Lmna (−/−) Mice
por: Frock, Richard L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8v7kd49i3l0ai1a13v94o2he66